What Investors Are Looking At In The Stem Cell Sector – Benzinga
|
What Investors Are Looking At In The Stem Cell Sector
Benzinga Pluristem Therapeutics Inc. (NASDAQ: PSTI) is a stem cell company that is partnered with United Therapeutics Corporation (NASDAQ: UTHR). The companies are conducting a Phase 1 trial of PLX-PAD for pulmonary arterial hypertension. Safety data is … |
